Indication

Mycobacterium bovis BCG

1 clinical trial

1 product

Clinical trial

Systemic Immunological Response of Bladder Cancer Patients Under Bacillus Calmette Guérin Treatment

Status: , Estimated PCD: 2026-12-18

Product

Bacillus Calmette Guerin